Defining a role for endoscopic ultrasound in staging periampullary tumors

Citation
M. Shoup et al., Defining a role for endoscopic ultrasound in staging periampullary tumors, AM J SURG, 179(6), 2000, pp. 453-456
Citations number
24
Categorie Soggetti
Surgery,"Medical Research Diagnosis & Treatment
Journal title
AMERICAN JOURNAL OF SURGERY
ISSN journal
00029610 → ACNP
Volume
179
Issue
6
Year of publication
2000
Pages
453 - 456
Database
ISI
SICI code
0002-9610(200006)179:6<453:DARFEU>2.0.ZU;2-6
Abstract
BACKGROUND: The goal of the preoperative workup in patients with suspected periampullary carcinoma is to establish the diagnosis with a high degree of certainty. In this study we compared endoscopic ultrasonography (EUS) and computed tomography (CT) scans for the detection of tumor, lymph node metas tasis, and vascular invasion in patients with suspected periampullary carci noma in order to define a role for EUS in the preoperative staging of these patients. METHODS: Thirty-seven consecutive patients received EUS and CT scanning fol lowed by operation for presumed periampullary carcinoma during a 30-month p eriod. Both imaging modalities were reviewed in a blinded fashion and the r esults compared with pathology and operative reports on all patients. RESULTS: Sensitivity, specificity, positive predictive value, and negative predictive value for tumor detection by EUS were 97%, 33%, 94%, and 50%, re spectively, compared with 82%, 66%, 97%, and 25% for CT scan. For lymph nod es the values were 21%, 80%, 57%, and 44%, respectively, for EUS compared w ith 42%, 73%, 67%, and 50% for CT, For vascular invasion, the values were 2 0%, 100%, 100%, and 89%, respectively, for EUS, compared with 80%, 87%, 44% , and 96% for CT. CONCLUSIONS: CT is the initial study of choice in patients with suspected p eriampullary tumors. EUS is superior for detecting tumor and for predicting vascular invasion. Therefore, EUS should be used for patients in whom CT d oes not detect a mass and for those with an identifiable mass on CT in whom vascular invasion cannot be ruled out. (C) 2000 by Excerpta Medica, Inc.